Evolus, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EOLS Nasdaq 2830 www.evolus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Evolus, Inc.

Why Evolus Stock Soared Today - Mar 4th, 2026 9:05 pm
Evolus, Inc. Q4 2025 Earnings Call Summary - Mar 4th, 2026 6:30 am
Evolus Inc (EOLS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Mar 3rd, 2026 10:01 pm
Evolus Q4 Earnings Call Highlights - Mar 3rd, 2026 5:02 pm
Evolus (EOLS) Q4 2025 Earnings Call Transcript - Mar 3rd, 2026 4:11 pm
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates - Mar 3rd, 2026 4:05 pm
Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 - Mar 3rd, 2026 2:05 pm
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates - Feb 25th, 2026 5:25 pm
Evolus to Participate in The Leerink Partners Global Healthcare Conference - Feb 25th, 2026 6:00 am
Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Feb 24th, 2026 8:00 am
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 - Feb 17th, 2026 6:00 am
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb 13th, 2026 2:05 pm
What Catalysts Are Rewriting The Evolus (EOLS) Story After The Guidance Reset - Feb 10th, 2026 3:05 am
Mizuho Lowers Price Target on Evolus, Inc. (EOLS) to $15, Maintains Outperform Rating - Feb 9th, 2026 12:13 pm
How A New Price Target Is Shaping The Evolus (EOLS) Story - Jan 26th, 2026 6:06 am
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Jan 9th, 2026 6:30 am
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - Dec 28th, 2025 10:46 am
Mizuho Cuts Evolus (EOLS) Estimates for Jeuveau/Evolysse on Waning Consumer Sentiment and Inflationary Pressure on Elective Aesthetics - Dec 15th, 2025 9:10 pm
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability - Nov 27th, 2025 5:44 am
Evolus (EOLS) Q3 2025 Earnings Call Transcript - Nov 6th, 2025 7:52 am